Deciduous Therapeutics (Seed+)
Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
- $35,000,000
Company Info
- Founders
- Robin Mansukhani
- Company Description
- Developing multiple activation approaches to clearing senescent cells via novel immunotherapies. Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.
- Market
- Healthcare & Wellness
- Coinvestors
- BOLD Capital Partners